Araris Biotech (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:
Biotech
Business model:
B2B
Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich pioneering a novel antibody-drug conjugate (ADC)-linker technology.
Investors:
we tracked 8 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 40.78m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom